Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia

Published:2013-02-06 Issue:8 Volume:28 Page:1088-1096
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Bezard Erwan¹²³,Tronci Elisabetta⁴⁵,Pioli Elsa Y.⁶,Li Qin³⁶,Porras Gregory⁶,Björklund Anders⁵,Carta Manolo⁴⁵

Affiliation:

1. Institute for Neurodegenerative Diseases; Bordeaux University; Bordeaux France

2. Institute for Neurodegenerative Diseases; National Center for Scientific Research; Bordeaux France

3. Institute of Laboratory Animal Sciences; China Academy of Medical Sciences; Beijing China

4. Physiology Section, Department of Biomedical Sciences; Cagliari University; Cagliari Italy

5. Neurobiology Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science; Lund University; Lund Sweden

6. Motac Neuroscience Ltd.; Manchester United Kingdom

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference24 articles.

1. Amantadine for dyskinesias in Parkinson's disease: a randomized controlled trial [serial online];Sawada;PLoS One,2010

2. Priorities in Parkinson's disease research;Meissner;Nat Rev Drug Discov,2011

3. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats;Carta;Brain,2007

4. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia;Munoz;Brain,2008

5. Chronic l-dopa therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease;Navailles;Neurobiol Dis,2011

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The chronic use of serotonin norepinephrine reuptake inhibitors facilitates dyskinesia priming in early Parkinson’s disease;Journal of Neurology;2024-05-08

2. Using artificial intelligence to identify drugs for repurposing to treat l-DOPA-induced dyskinesia;Neuropharmacology;2024-05

3. Novel and experimental therapeutics for the management of motor and non-motor Parkinsonian symptoms;Neurological Sciences;2024-02-23

4. Levodopa-Induced Dyskinesias in Parkinson’s Disease: An Overview on Pathophysiology, Clinical Manifestations, Therapy Management Strategies and Future Directions;Journal of Clinical Medicine;2023-06-30

5. Broad Serotonergic Actions of Vortioxetine as a Promising Avenue for the Treatment of L-DOPA-Induced Dyskinesia;Cells;2023-03-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3